nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—DCK—hematologic cancer	0.09	0.816	CbGaD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Nelarabine—hematologic cancer	0.085	0.308	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Pentostatin—hematologic cancer	0.085	0.308	CiPCiCtD
Clofarabine—Nelarabine—hematologic cancer	0.066	0.309	CrCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0644	0.233	CiPCiCtD
Clofarabine—Fludarabine—hematologic cancer	0.0515	0.241	CrCtD
Clofarabine—Cytarabine—hematologic cancer	0.0486	0.228	CrCtD
Clofarabine—Cladribine—hematologic cancer	0.0474	0.222	CrCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0415	0.15	CiPCiCtD
Clofarabine—ABCG2—hematologic cancer	0.0203	0.184	CbGaD
Clofarabine—POLA1—Nelarabine—hematologic cancer	0.0194	0.108	CbGbCtD
Clofarabine—RRM1—Fludarabine—hematologic cancer	0.0155	0.0868	CbGbCtD
Clofarabine—RRM1—Hydroxyurea—hematologic cancer	0.0144	0.0807	CbGbCtD
Clofarabine—RRM2—Hydroxyurea—hematologic cancer	0.0144	0.0807	CbGbCtD
Clofarabine—POLA1—Fludarabine—hematologic cancer	0.0134	0.075	CbGbCtD
Clofarabine—DCK—Nelarabine—hematologic cancer	0.0119	0.0667	CbGbCtD
Clofarabine—RRM2—Cladribine—hematologic cancer	0.01	0.0559	CbGbCtD
Clofarabine—RRM1—Cladribine—hematologic cancer	0.01	0.0559	CbGbCtD
Clofarabine—POLA1—Cytarabine—hematologic cancer	0.00915	0.0512	CbGbCtD
Clofarabine—POLA1—Cladribine—hematologic cancer	0.00864	0.0484	CbGbCtD
Clofarabine—DCK—Fludarabine—hematologic cancer	0.00826	0.0462	CbGbCtD
Clofarabine—RRM2—Gemcitabine—hematologic cancer	0.00645	0.0361	CbGbCtD
Clofarabine—RRM1—Gemcitabine—hematologic cancer	0.00645	0.0361	CbGbCtD
Clofarabine—DCK—Cytarabine—hematologic cancer	0.00564	0.0315	CbGbCtD
Clofarabine—POLA1—Gemcitabine—hematologic cancer	0.00557	0.0312	CbGbCtD
Clofarabine—DCK—Cladribine—hematologic cancer	0.00532	0.0298	CbGbCtD
Clofarabine—Ribavirin—Nelarabine—hematologic cancer	0.00459	0.031	CrCrCtD
Clofarabine—Regadenoson—Nelarabine—hematologic cancer	0.00428	0.029	CrCrCtD
Clofarabine—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.00428	0.029	CrCrCtD
Clofarabine—Azacitidine—Pentostatin—hematologic cancer	0.00406	0.0275	CrCrCtD
Clofarabine—Cladribine—Pentostatin—hematologic cancer	0.00406	0.0275	CrCrCtD
Clofarabine—Vidarabine—Pentostatin—hematologic cancer	0.00406	0.0275	CrCrCtD
Clofarabine—Adenosine—Pentostatin—hematologic cancer	0.00406	0.0275	CrCrCtD
Clofarabine—Fludarabine—Nelarabine—hematologic cancer	0.00401	0.0272	CrCrCtD
Clofarabine—Decitabine—Pentostatin—hematologic cancer	0.00386	0.0262	CrCrCtD
Clofarabine—Adenosine monophosphate—Nelarabine—hematologic cancer	0.00378	0.0256	CrCrCtD
Clofarabine—Ribavirin—Fludarabine—hematologic cancer	0.00358	0.0242	CrCrCtD
Clofarabine—Cytarabine—Nelarabine—hematologic cancer	0.00358	0.0242	CrCrCtD
Clofarabine—DCK—Gemcitabine—hematologic cancer	0.00343	0.0192	CbGbCtD
Clofarabine—Azacitidine—Nelarabine—hematologic cancer	0.0034	0.023	CrCrCtD
Clofarabine—Vidarabine—Nelarabine—hematologic cancer	0.0034	0.023	CrCrCtD
Clofarabine—Cladribine—Nelarabine—hematologic cancer	0.0034	0.023	CrCrCtD
Clofarabine—Adenosine—Nelarabine—hematologic cancer	0.0034	0.023	CrCrCtD
Clofarabine—Ribavirin—Cytarabine—hematologic cancer	0.00338	0.0229	CrCrCtD
Clofarabine—Regadenoson—Fludarabine—hematologic cancer	0.00334	0.0226	CrCrCtD
Clofarabine—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.00334	0.0226	CrCrCtD
Clofarabine—Decitabine—Nelarabine—hematologic cancer	0.00324	0.0219	CrCrCtD
Clofarabine—Regadenoson—Cytarabine—hematologic cancer	0.00315	0.0213	CrCrCtD
Clofarabine—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.00315	0.0213	CrCrCtD
Clofarabine—Regadenoson—Cladribine—hematologic cancer	0.00307	0.0208	CrCrCtD
Clofarabine—Fludarabine—Cytarabine—hematologic cancer	0.00296	0.02	CrCrCtD
Clofarabine—Nelarabine—Fludarabine—hematologic cancer	0.00295	0.02	CrCrCtD
Clofarabine—Adenosine monophosphate—Fludarabine—hematologic cancer	0.00295	0.02	CrCrCtD
Clofarabine—Fludarabine—Cladribine—hematologic cancer	0.00288	0.0195	CrCrCtD
Clofarabine—Cytarabine—Fludarabine—hematologic cancer	0.00279	0.0189	CrCrCtD
Clofarabine—Nelarabine—Cytarabine—hematologic cancer	0.00279	0.0189	CrCrCtD
Clofarabine—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00279	0.0189	CrCrCtD
Clofarabine—Nelarabine—Cladribine—hematologic cancer	0.00272	0.0184	CrCrCtD
Clofarabine—Adenosine monophosphate—Cladribine—hematologic cancer	0.00272	0.0184	CrCrCtD
Clofarabine—Adenosine—Fludarabine—hematologic cancer	0.00265	0.018	CrCrCtD
Clofarabine—Vidarabine—Fludarabine—hematologic cancer	0.00265	0.018	CrCrCtD
Clofarabine—Cladribine—Fludarabine—hematologic cancer	0.00265	0.018	CrCrCtD
Clofarabine—Azacitidine—Fludarabine—hematologic cancer	0.00265	0.018	CrCrCtD
Clofarabine—Cytarabine—Gemcitabine—hematologic cancer	0.00264	0.0179	CrCrCtD
Clofarabine—Azacitidine—Gemcitabine—hematologic cancer	0.00251	0.017	CrCrCtD
Clofarabine—Adenosine—Cytarabine—hematologic cancer	0.00251	0.017	CrCrCtD
Clofarabine—Vidarabine—Cytarabine—hematologic cancer	0.00251	0.017	CrCrCtD
Clofarabine—Azacitidine—Cytarabine—hematologic cancer	0.00251	0.017	CrCrCtD
Clofarabine—Adenosine—Cladribine—hematologic cancer	0.00244	0.0165	CrCrCtD
Clofarabine—Vidarabine—Cladribine—hematologic cancer	0.00244	0.0165	CrCrCtD
Clofarabine—Azacitidine—Cladribine—hematologic cancer	0.00244	0.0165	CrCrCtD
Clofarabine—Decitabine—Gemcitabine—hematologic cancer	0.00239	0.0162	CrCrCtD
Clofarabine—Decitabine—Cytarabine—hematologic cancer	0.00239	0.0162	CrCrCtD
Clofarabine—Decitabine—Cladribine—hematologic cancer	0.00233	0.0157	CrCrCtD
Clofarabine—ABCG2—Daunorubicin—hematologic cancer	0.00136	0.00761	CbGbCtD
Clofarabine—ABCG2—Teniposide—hematologic cancer	0.00118	0.00662	CbGbCtD
Clofarabine—ABCG2—Cladribine—hematologic cancer	0.00113	0.00634	CbGbCtD
Clofarabine—ABCG2—Imatinib—hematologic cancer	0.00104	0.00583	CbGbCtD
Clofarabine—ABCG2—Nilotinib—hematologic cancer	0.000948	0.0053	CbGbCtD
Clofarabine—ABCG2—Dasatinib—hematologic cancer	0.000838	0.00468	CbGbCtD
Clofarabine—ABCG2—Mitoxantrone—hematologic cancer	0.000827	0.00463	CbGbCtD
Clofarabine—ABCG2—Irinotecan—hematologic cancer	0.000651	0.00364	CbGbCtD
Clofarabine—ABCG2—Vincristine—hematologic cancer	0.000569	0.00318	CbGbCtD
Clofarabine—POLA1—hematopoietic system—hematologic cancer	0.000555	0.0638	CbGeAlD
Clofarabine—ABCG2—Cisplatin—hematologic cancer	0.000531	0.00297	CbGbCtD
Clofarabine—RRM2—hematopoietic system—hematologic cancer	0.000531	0.061	CbGeAlD
Clofarabine—ABCG2—Etoposide—hematologic cancer	0.000522	0.00292	CbGbCtD
Clofarabine—RRM1—hematopoietic system—hematologic cancer	0.000441	0.0507	CbGeAlD
Clofarabine—ABCG2—Dexamethasone—hematologic cancer	0.000429	0.0024	CbGbCtD
Clofarabine—RRM2—gonad—hematologic cancer	0.000403	0.0464	CbGeAlD
Clofarabine—POLA1—blood—hematologic cancer	0.000368	0.0423	CbGeAlD
Clofarabine—POLA1—bone marrow—hematologic cancer	0.000356	0.0409	CbGeAlD
Clofarabine—ABCG2—Doxorubicin—hematologic cancer	0.000356	0.00199	CbGbCtD
Clofarabine—RRM2—blood—hematologic cancer	0.000352	0.0404	CbGeAlD
Clofarabine—ABCG2—Methotrexate—hematologic cancer	0.000345	0.00193	CbGbCtD
Clofarabine—DCK—hematopoietic system—hematologic cancer	0.000342	0.0394	CbGeAlD
Clofarabine—RRM2—bone marrow—hematologic cancer	0.00034	0.0391	CbGeAlD
Clofarabine—RRM1—gonad—hematologic cancer	0.000335	0.0385	CbGeAlD
Clofarabine—POLA1—lung—hematologic cancer	0.000323	0.0371	CbGeAlD
Clofarabine—RRM2—lung—hematologic cancer	0.000308	0.0354	CbGeAlD
Clofarabine—POLA1—testis—hematologic cancer	0.000304	0.035	CbGeAlD
Clofarabine—RRM1—blood—hematologic cancer	0.000292	0.0336	CbGeAlD
Clofarabine—RRM2—testis—hematologic cancer	0.000291	0.0334	CbGeAlD
Clofarabine—RRM1—bone marrow—hematologic cancer	0.000283	0.0325	CbGeAlD
Clofarabine—DCK—gonad—hematologic cancer	0.00026	0.0299	CbGeAlD
Clofarabine—RRM1—lung—hematologic cancer	0.000256	0.0294	CbGeAlD
Clofarabine—RRM1—testis—hematologic cancer	0.000242	0.0278	CbGeAlD
Clofarabine—DCK—blood—hematologic cancer	0.000227	0.0261	CbGeAlD
Clofarabine—POLA1—lymph node—hematologic cancer	0.000221	0.0254	CbGeAlD
Clofarabine—DCK—bone marrow—hematologic cancer	0.000219	0.0252	CbGeAlD
Clofarabine—RRM2—lymph node—hematologic cancer	0.000211	0.0242	CbGeAlD
Clofarabine—DCK—lung—hematologic cancer	0.000199	0.0229	CbGeAlD
Clofarabine—DCK—testis—hematologic cancer	0.000188	0.0216	CbGeAlD
Clofarabine—RRM1—lymph node—hematologic cancer	0.000175	0.0201	CbGeAlD
Clofarabine—Azacitidine—DNMT3A—hematologic cancer	0.000142	0.131	CrCbGaD
Clofarabine—Decitabine—DNMT3A—hematologic cancer	0.000139	0.128	CrCbGaD
Clofarabine—DCK—lymph node—hematologic cancer	0.000136	0.0156	CbGeAlD
Clofarabine—Azacitidine—CDA—hematologic cancer	0.000127	0.117	CrCbGaD
Clofarabine—ABCG2—blood—hematologic cancer	0.000127	0.0145	CbGeAlD
Clofarabine—ABCG2—bone marrow—hematologic cancer	0.000122	0.0141	CbGeAlD
Clofarabine—ABCG2—lung—hematologic cancer	0.000111	0.0128	CbGeAlD
Clofarabine—Decitabine—DCK—hematologic cancer	0.000109	0.101	CrCbGaD
Clofarabine—Nelarabine—DCK—hematologic cancer	0.000105	0.0969	CrCbGaD
Clofarabine—ABCG2—testis—hematologic cancer	0.000105	0.012	CbGeAlD
Clofarabine—Fludarabine—DCK—hematologic cancer	9.87e-05	0.0913	CrCbGaD
Clofarabine—ABCG2—lymph node—hematologic cancer	7.59e-05	0.00872	CbGeAlD
Clofarabine—Cytarabine—CDA—hematologic cancer	7.22e-05	0.0668	CrCbGaD
Clofarabine—Adenosine monophosphate—CREB1—hematologic cancer	6.52e-05	0.0603	CrCbGaD
Clofarabine—Cytarabine—DCK—hematologic cancer	6.36e-05	0.0588	CrCbGaD
Clofarabine—Cladribine—DCK—hematologic cancer	5.85e-05	0.0541	CrCbGaD
Clofarabine—DCK—Topotecan—Irinotecan—hematologic cancer	5.14e-05	0.069	CbGdCrCtD
Clofarabine—POLA1—Vinblastine—Vinorelbine—hematologic cancer	4.84e-05	0.065	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Pentostatin—hematologic cancer	4.24e-05	0.057	CbGdCrCtD
Clofarabine—RRM2—Vinorelbine—Vincristine—hematologic cancer	4.09e-05	0.0549	CbGdCrCtD
Clofarabine—RRM2—Vinorelbine—Vinblastine—hematologic cancer	4.09e-05	0.0549	CbGdCrCtD
Clofarabine—POLA1—Vinblastine—Vincristine—hematologic cancer	3.87e-05	0.0519	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Nelarabine—hematologic cancer	3.56e-05	0.0478	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Daunorubicin—hematologic cancer	3.47e-05	0.0466	CbGdCrCtD
Clofarabine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	3.47e-05	0.0466	CbGdCrCtD
Clofarabine—DCK—Menadione—Thalidomide—hematologic cancer	2.95e-05	0.0396	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Fludarabine—hematologic cancer	2.78e-05	0.0373	CbGdCrCtD
Clofarabine—RRM2—Azacitidine—Pentostatin—hematologic cancer	2.66e-05	0.0358	CbGdCrCtD
Clofarabine—Adenosine monophosphate—SRC—hematologic cancer	2.64e-05	0.0244	CrCbGaD
Clofarabine—DCK—Epirubicin—Idarubicin—hematologic cancer	2.63e-05	0.0353	CbGdCrCtD
Clofarabine—DCK—Doxorubicin—Idarubicin—hematologic cancer	2.63e-05	0.0353	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Gemcitabine—hematologic cancer	2.62e-05	0.0352	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Cytarabine—hematologic cancer	2.62e-05	0.0352	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Cladribine—hematologic cancer	2.55e-05	0.0343	CbGdCrCtD
Clofarabine—Adenosine monophosphate—PDE4B—hematologic cancer	2.36e-05	0.0218	CrCbGaD
Clofarabine—RRM2—Azacitidine—Nelarabine—hematologic cancer	2.23e-05	0.03	CbGdCrCtD
Clofarabine—Cytarabine—SLC22A1—hematologic cancer	2.05e-05	0.019	CrCbGaD
Clofarabine—Cladribine—SLC22A1—hematologic cancer	1.89e-05	0.0175	CrCbGaD
Clofarabine—RRM2—Azacitidine—Fludarabine—hematologic cancer	1.74e-05	0.0234	CbGdCrCtD
Clofarabine—RRM2—Azacitidine—Gemcitabine—hematologic cancer	1.65e-05	0.0221	CbGdCrCtD
Clofarabine—RRM2—Azacitidine—Cytarabine—hematologic cancer	1.65e-05	0.0221	CbGdCrCtD
Clofarabine—RRM2—Azacitidine—Cladribine—hematologic cancer	1.6e-05	0.0215	CbGdCrCtD
Clofarabine—Cladribine—ABCG2—hematologic cancer	1.32e-05	0.0122	CrCbGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—hematologic cancer	1.21e-05	0.0162	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Doxorubicin—hematologic cancer	1.12e-05	0.015	CbGdCrCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK4—hematologic cancer	6.76e-06	0.000389	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TERT—hematologic cancer	6.75e-06	0.000388	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—IDH1—hematologic cancer	6.74e-06	0.000388	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NUP214—hematologic cancer	6.73e-06	0.000387	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.73e-06	0.000387	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.73e-06	0.000387	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.73e-06	0.000387	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ACP5—hematologic cancer	6.7e-06	0.000385	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CA9—hematologic cancer	6.7e-06	0.000385	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTO1—hematologic cancer	6.66e-06	0.000383	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TXN—hematologic cancer	6.66e-06	0.000383	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCC3—hematologic cancer	6.66e-06	0.000383	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOR2—hematologic cancer	6.61e-06	0.00038	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTR—hematologic cancer	6.6e-06	0.000379	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCG2—hematologic cancer	6.6e-06	0.000379	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—CDK2—hematologic cancer	6.54e-06	0.000376	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—hematologic cancer	6.53e-06	0.000375	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SPHK1—hematologic cancer	6.52e-06	0.000375	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ENO2—hematologic cancer	6.47e-06	0.000372	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.46e-06	0.000372	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—HSP90AA1—hematologic cancer	6.43e-06	0.00037	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK2—hematologic cancer	6.39e-06	0.000368	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.33e-06	0.000364	CbGpPWpGaD
Clofarabine—DCK—Metabolism—IDH1—hematologic cancer	6.3e-06	0.000362	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTT1—hematologic cancer	6.27e-06	0.000361	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—UGT1A1—hematologic cancer	6.27e-06	0.00036	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCC3—hematologic cancer	6.23e-06	0.000358	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TXN—hematologic cancer	6.23e-06	0.000358	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTO1—hematologic cancer	6.23e-06	0.000358	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	6.18e-06	0.000355	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.17e-06	0.000355	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND2—hematologic cancer	6.16e-06	0.000354	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.15e-06	0.000354	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SDC1—hematologic cancer	6.13e-06	0.000353	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CRABP1—hematologic cancer	6.09e-06	0.000351	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC22A1—hematologic cancer	6.09e-06	0.000351	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SPHK1—hematologic cancer	6.09e-06	0.000351	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.09e-06	0.00035	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—ATM—hematologic cancer	6.07e-06	0.000349	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.06e-06	0.000349	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK4—hematologic cancer	6.04e-06	0.000348	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FTCD—hematologic cancer	6e-06	0.000345	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PHYH—hematologic cancer	6e-06	0.000345	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GMPS—hematologic cancer	6e-06	0.000345	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	5.97e-06	0.000343	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	5.95e-06	0.000342	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALOX5—hematologic cancer	5.94e-06	0.000342	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—hematologic cancer	5.88e-06	0.000338	CbGpPWpGaD
Clofarabine—DCK—Metabolism—UGT1A1—hematologic cancer	5.85e-06	0.000337	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.82e-06	0.000335	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NUP98—hematologic cancer	5.75e-06	0.000331	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC22A1—hematologic cancer	5.7e-06	0.000328	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CRABP1—hematologic cancer	5.7e-06	0.000328	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.68e-06	0.000326	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ADCY7—hematologic cancer	5.58e-06	0.000321	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NCOA3—hematologic cancer	5.58e-06	0.000321	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALOX5—hematologic cancer	5.55e-06	0.000319	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NUP214—hematologic cancer	5.55e-06	0.000319	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2B—hematologic cancer	5.52e-06	0.000318	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.52e-06	0.000317	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SMPD3—hematologic cancer	5.49e-06	0.000316	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTR—hematologic cancer	5.43e-06	0.000312	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCG2—hematologic cancer	5.43e-06	0.000312	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.38e-06	0.000309	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NUP98—hematologic cancer	5.38e-06	0.000309	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—hematologic cancer	5.37e-06	0.000309	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Betamethasone—hematologic cancer	5.34e-06	0.00716	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	5.34e-06	0.00716	CbGdCrCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—hematologic cancer	5.33e-06	0.000307	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO2—hematologic cancer	5.33e-06	0.000306	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.32e-06	0.000306	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RB1—hematologic cancer	5.25e-06	0.000302	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ADCY7—hematologic cancer	5.22e-06	0.0003	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOA3—hematologic cancer	5.22e-06	0.0003	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NQO1—hematologic cancer	5.21e-06	0.0003	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CD44—hematologic cancer	5.21e-06	0.0003	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	5.21e-06	0.007	CbGdCrCtD
Clofarabine—DCK—Metabolism—NUP214—hematologic cancer	5.18e-06	0.000298	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Dexamethasone—hematologic cancer	5.18e-06	0.00695	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—hematologic cancer	5.18e-06	0.00695	CbGdCrCtD
Clofarabine—RRM2—Metabolism—GSTT1—hematologic cancer	5.17e-06	0.000297	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	5.17e-06	0.000297	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.09e-06	0.000292	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTR—hematologic cancer	5.08e-06	0.000292	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCG2—hematologic cancer	5.08e-06	0.000292	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Triamcinolone—hematologic cancer	5.06e-06	0.00679	CbGdCrCtD
Clofarabine—RRM2—Metabolism—SDC1—hematologic cancer	5.05e-06	0.00029	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ENO2—hematologic cancer	4.98e-06	0.000286	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisone—hematologic cancer	4.95e-06	0.00664	CbGdCrCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.95e-06	0.000284	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYCS—hematologic cancer	4.93e-06	0.000284	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.93e-06	0.000284	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HSP90AA1—hematologic cancer	4.9e-06	0.000282	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK2—hematologic cancer	4.89e-06	0.000281	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.87e-06	0.00028	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisolone—hematologic cancer	4.83e-06	0.00648	CbGdCrCtD
Clofarabine—DCK—Metabolism—GSTT1—hematologic cancer	4.83e-06	0.000278	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Prednisone—hematologic cancer	4.8e-06	0.00645	CbGdCrCtD
Clofarabine—ABCG2—Metabolism—DCK—hematologic cancer	4.8e-06	0.000276	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ASNS—hematologic cancer	4.8e-06	0.000276	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—B3GAT1—hematologic cancer	4.8e-06	0.000276	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BIRC5—hematologic cancer	4.77e-06	0.000274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SDC1—hematologic cancer	4.72e-06	0.000271	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Prednisolone—hematologic cancer	4.69e-06	0.00629	CbGdCrCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—hematologic cancer	4.62e-06	0.000266	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—hematologic cancer	4.62e-06	0.000266	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—hematologic cancer	4.62e-06	0.000266	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.61e-06	0.000265	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.59e-06	0.000264	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	4.57e-06	0.000263	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.57e-06	0.000263	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HDC—hematologic cancer	4.55e-06	0.000262	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—hematologic cancer	4.48e-06	0.000258	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.46e-06	0.000256	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.43e-06	0.000255	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	4.39e-06	0.000252	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK2—hematologic cancer	4.37e-06	0.000252	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—hematologic cancer	4.36e-06	0.000251	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTP1—hematologic cancer	4.35e-06	0.00025	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CD44—hematologic cancer	4.29e-06	0.000247	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NQO1—hematologic cancer	4.29e-06	0.000247	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	4.22e-06	0.000243	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.2e-06	0.000241	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CDA—hematologic cancer	4.16e-06	0.000239	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—ATM—hematologic cancer	4.15e-06	0.000239	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK4—hematologic cancer	4.13e-06	0.000238	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCB1—hematologic cancer	4.12e-06	0.000237	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—hematologic cancer	4.09e-06	0.000235	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYCS—hematologic cancer	4.06e-06	0.000234	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.06e-06	0.000234	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HSP90AA1—hematologic cancer	4.04e-06	0.000232	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—hematologic cancer	4.02e-06	0.000231	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—hematologic cancer	4.02e-06	0.000231	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NQO1—hematologic cancer	4.01e-06	0.000231	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CD44—hematologic cancer	4.01e-06	0.000231	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PC—hematologic cancer	4e-06	0.00023	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NCOR1—hematologic cancer	4e-06	0.00023	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—hematologic cancer	4e-06	0.00023	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—hematologic cancer	3.9e-06	0.000224	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC35B2—hematologic cancer	3.87e-06	0.000222	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GBA—hematologic cancer	3.87e-06	0.000222	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.87e-06	0.000222	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYCS—hematologic cancer	3.8e-06	0.000218	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—hematologic cancer	3.78e-06	0.000217	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HSP90AA1—hematologic cancer	3.77e-06	0.000217	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—hematologic cancer	3.6e-06	0.000207	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RB1—hematologic cancer	3.59e-06	0.000207	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—hematologic cancer	3.59e-06	0.000207	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—hematologic cancer	3.58e-06	0.000206	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTAP—hematologic cancer	3.54e-06	0.000203	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	3.53e-06	0.000203	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—hematologic cancer	3.53e-06	0.000203	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—hematologic cancer	3.5e-06	0.000201	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.43e-06	0.000197	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCB1—hematologic cancer	3.39e-06	0.000195	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—hematologic cancer	3.35e-06	0.000193	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—hematologic cancer	3.29e-06	0.000189	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NCOR1—hematologic cancer	3.29e-06	0.000189	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—hematologic cancer	3.29e-06	0.000189	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.24e-06	0.000187	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—hematologic cancer	3.22e-06	0.000185	CbGpPWpGaD
Clofarabine—Anxiety—Prednisone—hematologic cancer	3.21e-06	6.98e-05	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—hematologic cancer	3.21e-06	6.98e-05	CcSEcCtD
Clofarabine—Vomiting—Gemcitabine—hematologic cancer	3.2e-06	6.97e-05	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.19e-06	6.95e-05	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—hematologic cancer	3.18e-06	6.92e-05	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—hematologic cancer	3.18e-06	6.92e-05	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—hematologic cancer	3.18e-06	6.92e-05	CcSEcCtD
Clofarabine—Rash—Gemcitabine—hematologic cancer	3.18e-06	6.92e-05	CcSEcCtD
Clofarabine—Dermatitis—Gemcitabine—hematologic cancer	3.17e-06	6.91e-05	CcSEcCtD
Clofarabine—Hypersensitivity—Etoposide—hematologic cancer	3.17e-06	6.9e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—ABCB1—hematologic cancer	3.17e-06	0.000182	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—hematologic cancer	3.16e-06	0.000182	CbGpPWpGaD
Clofarabine—Malnutrition—Methotrexate—hematologic cancer	3.16e-06	6.87e-05	CcSEcCtD
Clofarabine—Erythema—Methotrexate—hematologic cancer	3.16e-06	6.87e-05	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—hematologic cancer	3.16e-06	6.87e-05	CcSEcCtD
Clofarabine—Headache—Gemcitabine—hematologic cancer	3.16e-06	6.87e-05	CcSEcCtD
Clofarabine—Nausea—Vincristine—hematologic cancer	3.15e-06	6.87e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—FHL2—hematologic cancer	3.15e-06	0.000181	CbGpPWpGaD
Clofarabine—Flushing—Epirubicin—hematologic cancer	3.15e-06	6.86e-05	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—hematologic cancer	3.15e-06	6.86e-05	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—hematologic cancer	3.14e-06	6.84e-05	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MYC—hematologic cancer	3.13e-06	0.00018	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	3.13e-06	0.00018	CbGpPWpGaD
Clofarabine—Hypersensitivity—Prednisolone—hematologic cancer	3.13e-06	6.81e-05	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—hematologic cancer	3.1e-06	6.75e-05	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—hematologic cancer	3.09e-06	6.74e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—AGRN—hematologic cancer	3.09e-06	0.000178	CbGpPWpGaD
Clofarabine—Asthenia—Etoposide—hematologic cancer	3.09e-06	6.72e-05	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.09e-06	6.72e-05	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—hematologic cancer	3.08e-06	6.72e-05	CcSEcCtD
Clofarabine—Oedema—Prednisone—hematologic cancer	3.08e-06	6.71e-05	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—hematologic cancer	3.08e-06	6.7e-05	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—hematologic cancer	3.08e-06	6.7e-05	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—hematologic cancer	3.08e-06	6.7e-05	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—hematologic cancer	3.08e-06	6.7e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—NCOR1—hematologic cancer	3.08e-06	0.000177	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—hematologic cancer	3.08e-06	0.000177	CbGpPWpGaD
Clofarabine—Nausea—Mitoxantrone—hematologic cancer	3.07e-06	6.69e-05	CcSEcCtD
Clofarabine—Nausea—Irinotecan—hematologic cancer	3.07e-06	6.69e-05	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—hematologic cancer	3.07e-06	6.68e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MDM2—hematologic cancer	3.06e-06	0.000176	CbGpPWpGaD
Clofarabine—Infection—Prednisone—hematologic cancer	3.06e-06	6.67e-05	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—hematologic cancer	3.06e-06	6.66e-05	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.06e-06	6.66e-05	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.06e-06	6.66e-05	CcSEcCtD
Clofarabine—Back pain—Methotrexate—hematologic cancer	3.05e-06	6.65e-05	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—hematologic cancer	3.05e-06	6.65e-05	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—hematologic cancer	3.05e-06	6.65e-05	CcSEcCtD
Clofarabine—Chills—Epirubicin—hematologic cancer	3.05e-06	6.63e-05	CcSEcCtD
Clofarabine—Pruritus—Etoposide—hematologic cancer	3.04e-06	6.63e-05	CcSEcCtD
Clofarabine—Pain—Dexamethasone—hematologic cancer	3.03e-06	6.59e-05	CcSEcCtD
Clofarabine—Pain—Betamethasone—hematologic cancer	3.03e-06	6.59e-05	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—hematologic cancer	3.02e-06	6.58e-05	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—hematologic cancer	3.01e-06	6.55e-05	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—hematologic cancer	3e-06	6.53e-05	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—hematologic cancer	2.99e-06	6.52e-05	CcSEcCtD
Clofarabine—Nausea—Gemcitabine—hematologic cancer	2.99e-06	6.52e-05	CcSEcCtD
Clofarabine—Vomiting—Cisplatin—hematologic cancer	2.99e-06	6.5e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—hematologic cancer	2.99e-06	0.000172	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Prednisone—hematologic cancer	2.98e-06	6.49e-05	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—hematologic cancer	2.97e-06	6.47e-05	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—hematologic cancer	2.97e-06	6.47e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3CG—hematologic cancer	2.97e-06	0.000171	CbGpPWpGaD
Clofarabine—Rash—Cisplatin—hematologic cancer	2.96e-06	6.45e-05	CcSEcCtD
Clofarabine—Dermatitis—Cisplatin—hematologic cancer	2.96e-06	6.44e-05	CcSEcCtD
Clofarabine—Erythema—Epirubicin—hematologic cancer	2.95e-06	6.43e-05	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—hematologic cancer	2.95e-06	6.43e-05	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—hematologic cancer	2.94e-06	6.41e-05	CcSEcCtD
Clofarabine—Anorexia—Prednisone—hematologic cancer	2.94e-06	6.4e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—IDH2—hematologic cancer	2.93e-06	0.000169	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMMR—hematologic cancer	2.93e-06	0.000169	CbGpPWpGaD
Clofarabine—Anaemia—Methotrexate—hematologic cancer	2.92e-06	6.35e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—hematologic cancer	2.92e-06	6.35e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—hematologic cancer	2.92e-06	6.35e-05	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—hematologic cancer	2.91e-06	6.35e-05	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—hematologic cancer	2.91e-06	6.35e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—MTHFR—hematologic cancer	2.91e-06	0.000167	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.9e-06	6.3e-05	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.9e-06	6.3e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.89e-06	0.000166	CbGpPWpGaD
Clofarabine—Hypersensitivity—Triamcinolone—hematologic cancer	2.87e-06	6.26e-05	CcSEcCtD
Clofarabine—Back pain—Epirubicin—hematologic cancer	2.86e-06	6.22e-05	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—hematologic cancer	2.85e-06	6.2e-05	CcSEcCtD
Clofarabine—Dizziness—Etoposide—hematologic cancer	2.84e-06	6.19e-05	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—hematologic cancer	2.84e-06	6.18e-05	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.83e-06	6.16e-05	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—hematologic cancer	2.83e-06	6.15e-05	CcSEcCtD
Clofarabine—Chills—Doxorubicin—hematologic cancer	2.82e-06	6.14e-05	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.81e-06	6.12e-05	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—hematologic cancer	2.81e-06	6.11e-05	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—hematologic cancer	2.8e-06	6.1e-05	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—hematologic cancer	2.8e-06	6.09e-05	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—hematologic cancer	2.8e-06	6.09e-05	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—hematologic cancer	2.8e-06	6.09e-05	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—hematologic cancer	2.8e-06	6.09e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN1B—hematologic cancer	2.8e-06	0.000161	CbGpPWpGaD
Clofarabine—Nausea—Cisplatin—hematologic cancer	2.79e-06	6.07e-05	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—hematologic cancer	2.78e-06	6.04e-05	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—hematologic cancer	2.77e-06	6.03e-05	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—hematologic cancer	2.76e-06	6.01e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ARNTL—hematologic cancer	2.76e-06	0.000158	CbGpPWpGaD
Clofarabine—Cough—Methotrexate—hematologic cancer	2.76e-06	6e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—CREBBP—hematologic cancer	2.75e-06	0.000158	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—hematologic cancer	2.75e-06	5.99e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—hematologic cancer	2.75e-06	0.000158	CbGpPWpGaD
Clofarabine—Vomiting—Etoposide—hematologic cancer	2.74e-06	5.96e-05	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—hematologic cancer	2.73e-06	5.95e-05	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—hematologic cancer	2.73e-06	5.95e-05	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—hematologic cancer	2.73e-06	5.95e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—MTHFR—hematologic cancer	2.72e-06	0.000156	CbGpPWpGaD
Clofarabine—Agitation—Epirubicin—hematologic cancer	2.72e-06	5.91e-05	CcSEcCtD
Clofarabine—Rash—Etoposide—hematologic cancer	2.71e-06	5.91e-05	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—hematologic cancer	2.71e-06	5.9e-05	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.71e-06	0.000156	CbGpPWpGaD
Clofarabine—Headache—Etoposide—hematologic cancer	2.7e-06	5.87e-05	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—hematologic cancer	2.69e-06	5.85e-05	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—hematologic cancer	2.69e-06	5.85e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CA9—hematologic cancer	2.68e-06	0.000154	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACP5—hematologic cancer	2.68e-06	0.000154	CbGpPWpGaD
Clofarabine—Decreased appetite—Prednisone—hematologic cancer	2.68e-06	5.84e-05	CcSEcCtD
Clofarabine—Rash—Prednisolone—hematologic cancer	2.68e-06	5.82e-05	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—hematologic cancer	2.67e-06	5.82e-05	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.67e-06	5.81e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CCND1—hematologic cancer	2.67e-06	0.000154	CbGpPWpGaD
Clofarabine—Fatigue—Prednisone—hematologic cancer	2.66e-06	5.79e-05	CcSEcCtD
Clofarabine—Headache—Prednisolone—hematologic cancer	2.66e-06	5.79e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NCOR2—hematologic cancer	2.65e-06	0.000152	CbGpPWpGaD
Clofarabine—Leukopenia—Epirubicin—hematologic cancer	2.64e-06	5.76e-05	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—hematologic cancer	2.64e-06	5.76e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3CD—hematologic cancer	2.61e-06	0.00015	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—hematologic cancer	2.58e-06	0.000149	CbGpPWpGaD
Clofarabine—Dizziness—Triamcinolone—hematologic cancer	2.58e-06	5.62e-05	CcSEcCtD
Clofarabine—Cough—Epirubicin—hematologic cancer	2.58e-06	5.61e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—ALB—hematologic cancer	2.58e-06	0.000148	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—hematologic cancer	2.57e-06	0.000148	CbGpPWpGaD
Clofarabine—Infection—Methotrexate—hematologic cancer	2.56e-06	5.57e-05	CcSEcCtD
Clofarabine—Nausea—Etoposide—hematologic cancer	2.56e-06	5.56e-05	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—hematologic cancer	2.55e-06	5.55e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—hematologic cancer	2.54e-06	5.53e-05	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—hematologic cancer	2.54e-06	5.53e-05	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—hematologic cancer	2.54e-06	5.53e-05	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—hematologic cancer	2.53e-06	5.5e-05	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—hematologic cancer	2.53e-06	5.5e-05	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—hematologic cancer	2.52e-06	5.49e-05	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—hematologic cancer	2.52e-06	5.49e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—IDH1—hematologic cancer	2.52e-06	0.000145	CbGpPWpGaD
Clofarabine—Nausea—Prednisolone—hematologic cancer	2.52e-06	5.49e-05	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—hematologic cancer	2.52e-06	5.48e-05	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—hematologic cancer	2.52e-06	5.48e-05	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—hematologic cancer	2.51e-06	5.47e-05	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—hematologic cancer	2.51e-06	5.46e-05	CcSEcCtD
Clofarabine—Pruritus—Dexamethasone—hematologic cancer	2.5e-06	5.45e-05	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—hematologic cancer	2.5e-06	5.45e-05	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—hematologic cancer	2.5e-06	5.45e-05	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.5e-06	5.44e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—TXN—hematologic cancer	2.49e-06	0.000143	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTO1—hematologic cancer	2.49e-06	0.000143	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCC3—hematologic cancer	2.49e-06	0.000143	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Methotrexate—hematologic cancer	2.49e-06	5.42e-05	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—hematologic cancer	2.48e-06	5.4e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3R1—hematologic cancer	2.46e-06	0.000142	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.46e-06	0.000142	CbGpPWpGaD
Clofarabine—Rash—Triamcinolone—hematologic cancer	2.46e-06	5.36e-05	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—hematologic cancer	2.46e-06	5.35e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—EP300—hematologic cancer	2.46e-06	0.000141	CbGpPWpGaD
Clofarabine—Anorexia—Methotrexate—hematologic cancer	2.46e-06	5.35e-05	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—hematologic cancer	2.45e-06	5.33e-05	CcSEcCtD
Clofarabine—Headache—Triamcinolone—hematologic cancer	2.44e-06	5.32e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—PIK3CG—hematologic cancer	2.44e-06	0.000141	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SPHK1—hematologic cancer	2.44e-06	0.00014	CbGpPWpGaD
Clofarabine—Body temperature increased—Prednisone—hematologic cancer	2.44e-06	5.31e-05	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—hematologic cancer	2.44e-06	5.31e-05	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—hematologic cancer	2.42e-06	5.27e-05	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—hematologic cancer	2.42e-06	5.27e-05	CcSEcCtD
Clofarabine—Oedema—Epirubicin—hematologic cancer	2.41e-06	5.25e-05	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—hematologic cancer	2.41e-06	5.24e-05	CcSEcCtD
Clofarabine—Infection—Epirubicin—hematologic cancer	2.4e-06	5.22e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—hematologic cancer	2.39e-06	0.000138	CbGpPWpGaD
Clofarabine—Cough—Doxorubicin—hematologic cancer	2.39e-06	5.19e-05	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—hematologic cancer	2.36e-06	5.15e-05	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—hematologic cancer	2.36e-06	5.14e-05	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—hematologic cancer	2.36e-06	5.14e-05	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—hematologic cancer	2.35e-06	5.12e-05	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.35e-06	5.11e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—UGT1A1—hematologic cancer	2.34e-06	0.000135	CbGpPWpGaD
Clofarabine—Skin disorder—Epirubicin—hematologic cancer	2.34e-06	5.1e-05	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—hematologic cancer	2.34e-06	5.1e-05	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—hematologic cancer	2.34e-06	5.1e-05	CcSEcCtD
Clofarabine—Hyperhidrosis—Epirubicin—hematologic cancer	2.33e-06	5.08e-05	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—hematologic cancer	2.33e-06	5.07e-05	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—hematologic cancer	2.33e-06	5.07e-05	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—hematologic cancer	2.32e-06	5.05e-05	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—hematologic cancer	2.32e-06	5.05e-05	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—hematologic cancer	2.31e-06	5.04e-05	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.31e-06	5.03e-05	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—hematologic cancer	2.3e-06	5e-05	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—hematologic cancer	2.3e-06	5e-05	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—hematologic cancer	2.29e-06	4.99e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—PIK3CG—hematologic cancer	2.28e-06	0.000131	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CRABP1—hematologic cancer	2.28e-06	0.000131	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC22A1—hematologic cancer	2.28e-06	0.000131	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—hematologic cancer	2.27e-06	0.000131	CbGpPWpGaD
Clofarabine—Hypersensitivity—Prednisone—hematologic cancer	2.27e-06	4.95e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—CREBBP—hematologic cancer	2.27e-06	0.00013	CbGpPWpGaD
Clofarabine—Hypotension—Epirubicin—hematologic cancer	2.25e-06	4.91e-05	CcSEcCtD
Clofarabine—Vomiting—Betamethasone—hematologic cancer	2.25e-06	4.9e-05	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—hematologic cancer	2.25e-06	4.9e-05	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—hematologic cancer	2.24e-06	4.88e-05	CcSEcCtD
Clofarabine—Rash—Dexamethasone—hematologic cancer	2.23e-06	4.86e-05	CcSEcCtD
Clofarabine—Rash—Betamethasone—hematologic cancer	2.23e-06	4.86e-05	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—hematologic cancer	2.23e-06	4.86e-05	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—hematologic cancer	2.23e-06	4.86e-05	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—hematologic cancer	2.23e-06	4.86e-05	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.22e-06	4.84e-05	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—hematologic cancer	2.22e-06	4.84e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ALOX5—hematologic cancer	2.22e-06	0.000128	CbGpPWpGaD
Clofarabine—Headache—Dexamethasone—hematologic cancer	2.22e-06	4.83e-05	CcSEcCtD
Clofarabine—Headache—Betamethasone—hematologic cancer	2.22e-06	4.83e-05	CcSEcCtD
Clofarabine—Infection—Doxorubicin—hematologic cancer	2.22e-06	4.83e-05	CcSEcCtD
Clofarabine—Asthenia—Prednisone—hematologic cancer	2.21e-06	4.82e-05	CcSEcCtD
Clofarabine—Pain—Methotrexate—hematologic cancer	2.2e-06	4.8e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MAPK3—hematologic cancer	2.2e-06	0.000127	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.2e-06	4.78e-05	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—hematologic cancer	2.19e-06	4.76e-05	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.18e-06	4.76e-05	CcSEcCtD
Clofarabine—Pruritus—Prednisone—hematologic cancer	2.18e-06	4.75e-05	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—hematologic cancer	2.18e-06	4.74e-05	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—hematologic cancer	2.17e-06	4.72e-05	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—hematologic cancer	2.17e-06	4.71e-05	CcSEcCtD
Clofarabine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.16e-06	4.7e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NUP98—hematologic cancer	2.15e-06	0.000124	CbGpPWpGaD
Clofarabine—Dyspnoea—Epirubicin—hematologic cancer	2.15e-06	4.68e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—PIK3CD—hematologic cancer	2.15e-06	0.000124	CbGpPWpGaD
Clofarabine—Somnolence—Epirubicin—hematologic cancer	2.14e-06	4.67e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MYC—hematologic cancer	2.14e-06	0.000123	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—hematologic cancer	2.13e-06	4.63e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—hematologic cancer	2.12e-06	4.62e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—ALB—hematologic cancer	2.12e-06	0.000122	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CREBBP—hematologic cancer	2.12e-06	0.000122	CbGpPWpGaD
Clofarabine—Diarrhoea—Prednisone—hematologic cancer	2.11e-06	4.59e-05	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.11e-06	4.59e-05	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—hematologic cancer	2.1e-06	4.58e-05	CcSEcCtD
Clofarabine—Nausea—Betamethasone—hematologic cancer	2.1e-06	4.58e-05	CcSEcCtD
Clofarabine—Decreased appetite—Epirubicin—hematologic cancer	2.1e-06	4.56e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NCOA3—hematologic cancer	2.09e-06	0.00012	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ADCY7—hematologic cancer	2.09e-06	0.00012	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—hematologic cancer	2.08e-06	4.54e-05	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.08e-06	4.53e-05	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—hematologic cancer	2.08e-06	4.53e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NUP214—hematologic cancer	2.07e-06	0.000119	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—hematologic cancer	2.06e-06	4.49e-05	CcSEcCtD
Clofarabine—Dizziness—Prednisone—hematologic cancer	2.04e-06	4.44e-05	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—hematologic cancer	2.04e-06	4.44e-05	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—hematologic cancer	2.04e-06	4.44e-05	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.03e-06	4.43e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—MTR—hematologic cancer	2.03e-06	0.000117	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3R1—hematologic cancer	2.03e-06	0.000117	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—hematologic cancer	2.01e-06	0.000115	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—hematologic cancer	2e-06	4.36e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ENO2—hematologic cancer	1.99e-06	0.000115	CbGpPWpGaD
Clofarabine—Dyspnoea—Doxorubicin—hematologic cancer	1.99e-06	4.33e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—hematologic cancer	1.99e-06	4.33e-05	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—hematologic cancer	1.98e-06	4.32e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—ALB—hematologic cancer	1.98e-06	0.000114	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.97e-06	4.29e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—PTEN—hematologic cancer	1.97e-06	0.000113	CbGpPWpGaD
Clofarabine—Vomiting—Prednisone—hematologic cancer	1.96e-06	4.27e-05	CcSEcCtD
Clofarabine—Rash—Prednisone—hematologic cancer	1.94e-06	4.23e-05	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—hematologic cancer	1.94e-06	4.23e-05	CcSEcCtD
Clofarabine—Decreased appetite—Doxorubicin—hematologic cancer	1.94e-06	4.22e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GSTT1—hematologic cancer	1.93e-06	0.000111	CbGpPWpGaD
Clofarabine—Headache—Prednisone—hematologic cancer	1.93e-06	4.21e-05	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.93e-06	4.19e-05	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—hematologic cancer	1.92e-06	4.19e-05	CcSEcCtD
Clofarabine—Pain—Doxorubicin—hematologic cancer	1.91e-06	4.15e-05	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—hematologic cancer	1.91e-06	4.15e-05	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—hematologic cancer	1.91e-06	4.15e-05	CcSEcCtD
Clofarabine—Hypersensitivity—Methotrexate—hematologic cancer	1.9e-06	4.13e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—PIK3R1—hematologic cancer	1.9e-06	0.000109	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SDC1—hematologic cancer	1.89e-06	0.000109	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—hematologic cancer	1.87e-06	0.000108	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—hematologic cancer	1.87e-06	0.000108	CbGpPWpGaD
Clofarabine—Asthenia—Methotrexate—hematologic cancer	1.85e-06	4.03e-05	CcSEcCtD
Clofarabine—Feeling abnormal—Doxorubicin—hematologic cancer	1.84e-06	4e-05	CcSEcCtD
Clofarabine—Nausea—Prednisone—hematologic cancer	1.83e-06	3.99e-05	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.82e-06	3.97e-05	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—hematologic cancer	1.82e-06	3.97e-05	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.81e-06	0.000104	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—hematologic cancer	1.78e-06	3.87e-05	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—hematologic cancer	1.76e-06	3.84e-05	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—hematologic cancer	1.76e-06	3.84e-05	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—hematologic cancer	1.76e-06	3.84e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TP53—hematologic cancer	1.76e-06	0.000101	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—hematologic cancer	1.75e-06	0.000101	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—hematologic cancer	1.73e-06	3.77e-05	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—hematologic cancer	1.71e-06	3.71e-05	CcSEcCtD
Clofarabine—Dizziness—Methotrexate—hematologic cancer	1.7e-06	3.71e-05	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.69e-06	9.74e-05	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—hematologic cancer	1.65e-06	3.59e-05	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—hematologic cancer	1.64e-06	3.58e-05	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—hematologic cancer	1.64e-06	3.57e-05	CcSEcCtD
Clofarabine—Rash—Methotrexate—hematologic cancer	1.62e-06	3.54e-05	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—hematologic cancer	1.62e-06	3.53e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—PTEN—hematologic cancer	1.62e-06	9.31e-05	CbGpPWpGaD
Clofarabine—Headache—Methotrexate—hematologic cancer	1.61e-06	3.51e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NQO1—hematologic cancer	1.61e-06	9.24e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CD44—hematologic cancer	1.61e-06	9.24e-05	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—hematologic cancer	1.6e-06	3.49e-05	CcSEcCtD
Clofarabine—Dizziness—Epirubicin—hematologic cancer	1.59e-06	3.47e-05	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—hematologic cancer	1.58e-06	3.44e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—EP300—hematologic cancer	1.54e-06	8.88e-05	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—hematologic cancer	1.53e-06	3.34e-05	CcSEcCtD
Clofarabine—Nausea—Methotrexate—hematologic cancer	1.53e-06	3.33e-05	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—hematologic cancer	1.53e-06	3.32e-05	CcSEcCtD
Clofarabine—Rash—Epirubicin—hematologic cancer	1.52e-06	3.31e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CYCS—hematologic cancer	1.52e-06	8.74e-05	CbGpPWpGaD
Clofarabine—Dermatitis—Epirubicin—hematologic cancer	1.52e-06	3.31e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—PTEN—hematologic cancer	1.51e-06	8.7e-05	CbGpPWpGaD
Clofarabine—Headache—Epirubicin—hematologic cancer	1.51e-06	3.29e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—HSP90AA1—hematologic cancer	1.51e-06	8.68e-05	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—hematologic cancer	1.48e-06	3.21e-05	CcSEcCtD
Clofarabine—DCK—Metabolism—EP300—hematologic cancer	1.44e-06	8.29e-05	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—hematologic cancer	1.43e-06	3.12e-05	CcSEcCtD
Clofarabine—Vomiting—Doxorubicin—hematologic cancer	1.42e-06	3.09e-05	CcSEcCtD
Clofarabine—Rash—Doxorubicin—hematologic cancer	1.41e-06	3.06e-05	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—hematologic cancer	1.41e-06	3.06e-05	CcSEcCtD
Clofarabine—Headache—Doxorubicin—hematologic cancer	1.4e-06	3.04e-05	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3CA—hematologic cancer	1.39e-06	7.97e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—hematologic cancer	1.34e-06	7.7e-05	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—hematologic cancer	1.33e-06	2.89e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ABCB1—hematologic cancer	1.27e-06	7.29e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOR1—hematologic cancer	1.23e-06	7.08e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—hematologic cancer	1.23e-06	7.08e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—hematologic cancer	1.14e-06	6.57e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—hematologic cancer	1.13e-06	6.51e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—hematologic cancer	1.09e-06	6.26e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—hematologic cancer	1.07e-06	6.14e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—hematologic cancer	9.33e-07	5.36e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—hematologic cancer	9.14e-07	5.26e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—hematologic cancer	8.71e-07	5.01e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CREBBP—hematologic cancer	8.47e-07	4.87e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—hematologic cancer	8.03e-07	4.62e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—hematologic cancer	7.93e-07	4.56e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3R1—hematologic cancer	7.59e-07	4.36e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—hematologic cancer	7e-07	4.03e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—hematologic cancer	6.05e-07	3.48e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—hematologic cancer	5.77e-07	3.32e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—hematologic cancer	4.27e-07	2.46e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—hematologic cancer	3.49e-07	2.01e-05	CbGpPWpGaD
